MyFinsight

HomeAboutContact
Curious boy with magnifying glass
A worm made of letters APL
A worm made of letters BOA

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2024 MyFinsight. All rights reserved.

Bausch & Lomb Corp (BLCO)

For the quarter ending 2025-06-30, BLCO made $1,278M in revenue. -$62M in net income. Net profit margin of -4.85%.

Overview

Revenue
$1,278M
Net Income
-$62M
Net Profit Margin
-4.85%
EPS
-$0.18
Unit: Million (M) dollars
Revenue Breakdown
    • Vision Care
    • Pharmaceuticals
    • Surgical

Unit: Million (M) dollars (except for numbers of shares and EPS)
2025-06-30
2025-03-31
2024-09-30
2024-06-30
Total revenues1,278 1,137 1,196 1,216
Cost of goods sold (excluding amortization and impairments of intangible assets) and cost of other revenues- 482 464 482
Selling, general and administrative (note 4)579 563 511 535
Research and development96 86 84 84
Other expense, net-22 -22 -22 -14
Cost of goods sold (excluding amortization and impairments of intangible assets) and cost of other revenues-Product523 - - -
Cost of goods sold (excluding amortization and impairments of intangible assets) and cost of other revenues-Product And Service Other2 - - -
Amortization of intangible assets67 67 72 74
Total expenses1,289 1,220 1,153 1,190
Operating (loss) income-11 -83 43 26
Interest income3 3 4 3
Interest expense128 94 100 102
Loss on extinguishment of debt-9 - - -
Foreign exchange and other-2 -6 -5 -3
Loss before provision for income taxes-147 -180 -58 -76
Benefit from (provision for income taxes)-89 31 -66 72
Net loss-58 -211 8 -148
Net income attributable to noncontrolling interest4 1 4 3
Net loss attributable to bausch + lomb corporation-62 -212 4 -151
Basic loss per share attributable to bausch + lomb corporation (in usd per share)-0.18 -0.6 0.01 -0.43
Basic weighted-average common shares (in shares)353,700,000 352,800,000 351,900,000 351,800,000
Diluted loss per share attributable to bausch + lomb corporation (in usd per share)-0.18 -0.6 0.01 -0.43
Diluted weighted-average common shares (in shares)353,700,000 352,800,000 353,900,000 351,800,000
Unit: Million (M) dollars (except for numbers of shares and EPS)

Income Statement

DownloadDownload image
Net lossattributable to bausch + lomb...-$62M (58.94%↑ Y/Y)Net incomeattributable to...$4M (33.33%↑ Y/Y)Net loss-$58M (60.81%↑ Y/Y)Benefit from (provisionfor income taxes)-$89M (-223.61%↓ Y/Y)Loss beforeprovision for income taxes-$147M (-93.42%↓ Y/Y)Interest income$3M (0.00%↑ Y/Y)Pharmaceuticals$309M Surgical$216M Vision Care$753M Foreign exchange andother-$2M (33.33%↑ Y/Y)Loss onextinguishment of debt-$9M Interest expense$128M (25.49%↑ Y/Y)Operating (loss) income-$11M (-142.31%↓ Y/Y)Total revenues$1,278M (5.10%↑ Y/Y)Total expenses$1,289M (8.32%↑ Y/Y)Amortization of intangibleassets$67M (-9.46%↓ Y/Y)Cost of goods sold(excluding amortization...$2M Cost of goods sold(excluding amortization...$523M Other expense, net-$22M (-57.14%↓ Y/Y)Research and development$96M (14.29%↑ Y/Y)Selling, general andadministrative (note 4)$579M (8.22%↑ Y/Y)